Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs

Nematicide combinations may be a valid strategy to achieve effective nematode control in the presence of drug resistance. The goal of the current trial was to evaluate the pharmaco-parasitological performance of the moxidectin (MOX) and levamisole (LEV) combination after four years of continuous use...

Descripción completa

Detalles Bibliográficos
Autores principales: Luque Sonia, Lloberas, María Mercedes, Cardozo, Patricia Alejandra, Virkel, Guillermo, Farias, Cristina, Viviani, Paula, Lanusse, Carlos Edmundo, Alvarez, L., Lifschitz, Adrian Luis
Formato: info:ar-repo/semantics/artículo
Lenguaje:Inglés
Publicado: Elsevier 2021
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12123/8803
https://www.sciencedirect.com/science/article/abs/pii/S0304401721000224
https://doi.org/10.1016/j.vetpar.2021.109362
_version_ 1855036101574524928
author Luque Sonia
Lloberas, María Mercedes
Cardozo, Patricia Alejandra
Virkel, Guillermo
Farias, Cristina
Viviani, Paula
Lanusse, Carlos Edmundo
Alvarez, L.
Lifschitz, Adrian Luis
author_browse Alvarez, L.
Cardozo, Patricia Alejandra
Farias, Cristina
Lanusse, Carlos Edmundo
Lifschitz, Adrian Luis
Lloberas, María Mercedes
Luque Sonia
Virkel, Guillermo
Viviani, Paula
author_facet Luque Sonia
Lloberas, María Mercedes
Cardozo, Patricia Alejandra
Virkel, Guillermo
Farias, Cristina
Viviani, Paula
Lanusse, Carlos Edmundo
Alvarez, L.
Lifschitz, Adrian Luis
author_sort Luque Sonia
collection INTA Digital
description Nematicide combinations may be a valid strategy to achieve effective nematode control in the presence of drug resistance. The goal of the current trial was to evaluate the pharmaco-parasitological performance of the moxidectin (MOX) and levamisole (LEV) combination after four years of continuous use in lambs naturally parasitized with multi-resistant gastrointestinal nematodes. At the beginning of the trial, 40 lambs were divided into four groups (n = 10), which were untreated (control) or subcutaneously treated with MOX (0.2 mg/kg), LEV (8 mg/kg) or with the combination MOX + LEV (administered separately at 0.2 and 8 mg/kg, respectively). Blood samples were collected at different times post-treatment and LEV and MOX plasma concentrations were measured by HPLC. The clinical efficacy of the continuous use of MOX + LEV combination was assessed with the controlled efficacy test (CET), performed at the beginning and end of the study, and with the faecal egg count reduction (FECR) test, performed over the four-year study period. No significant adverse pharmacokinetic changes were observed either for MOX or LEV after their co-administration to infected lambs. The CET (first year) showed efficacies of 84.3 % (Haemonchus contortus), 100 % (Teladorsagia circumcincta and Trichostrongylus axei), and 97.4 % (T. colubriformis). After the repetitive use of the combined treatment for four years, those efficacies remained high (100 %) and only decreased to 58 % against T. colubriformis. The evaluation of the FECR over the study period showed fluctuations in the performance of the combined administration. The initial FECR (2014) was 99 % (MOX), 85 % (LEV) and 100 % (MOX + LEV). The co-administration of MOX + LEV during the four-year experimental period resulted in a significantly higher anthelmintic effect (87 %) than that of MOX (42 %) or LEV (69 %) given alone. The combined use of MOX + LEV to control resistant gastrointestinal nematodes appears to be a valid strategy under specific management conditions. A high initial therapeutic response to the combination would be a relevant feature for the success of this tool.
format info:ar-repo/semantics/artículo
id INTA8803
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Elsevier
publisherStr Elsevier
record_format dspace
spelling INTA88032022-09-14T16:06:54Z Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs Luque Sonia Lloberas, María Mercedes Cardozo, Patricia Alejandra Virkel, Guillermo Farias, Cristina Viviani, Paula Lanusse, Carlos Edmundo Alvarez, L. Lifschitz, Adrian Luis Ovinos Infecciones por Nematodos Medicamentos Levamisol Resistencia a los Antihelmínticos Argentina Sheep Nematode Infections Drugs Levamisole Resistence to Anthelmintics Nematicide combinations may be a valid strategy to achieve effective nematode control in the presence of drug resistance. The goal of the current trial was to evaluate the pharmaco-parasitological performance of the moxidectin (MOX) and levamisole (LEV) combination after four years of continuous use in lambs naturally parasitized with multi-resistant gastrointestinal nematodes. At the beginning of the trial, 40 lambs were divided into four groups (n = 10), which were untreated (control) or subcutaneously treated with MOX (0.2 mg/kg), LEV (8 mg/kg) or with the combination MOX + LEV (administered separately at 0.2 and 8 mg/kg, respectively). Blood samples were collected at different times post-treatment and LEV and MOX plasma concentrations were measured by HPLC. The clinical efficacy of the continuous use of MOX + LEV combination was assessed with the controlled efficacy test (CET), performed at the beginning and end of the study, and with the faecal egg count reduction (FECR) test, performed over the four-year study period. No significant adverse pharmacokinetic changes were observed either for MOX or LEV after their co-administration to infected lambs. The CET (first year) showed efficacies of 84.3 % (Haemonchus contortus), 100 % (Teladorsagia circumcincta and Trichostrongylus axei), and 97.4 % (T. colubriformis). After the repetitive use of the combined treatment for four years, those efficacies remained high (100 %) and only decreased to 58 % against T. colubriformis. The evaluation of the FECR over the study period showed fluctuations in the performance of the combined administration. The initial FECR (2014) was 99 % (MOX), 85 % (LEV) and 100 % (MOX + LEV). The co-administration of MOX + LEV during the four-year experimental period resulted in a significantly higher anthelmintic effect (87 %) than that of MOX (42 %) or LEV (69 %) given alone. The combined use of MOX + LEV to control resistant gastrointestinal nematodes appears to be a valid strategy under specific management conditions. A high initial therapeutic response to the combination would be a relevant feature for the success of this tool. EEA Balcarce Fil: Luque, Sonia Elisabet. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Lloberas, María Mercedes. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina. Fil: Cardozo, Patricia. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Balcarce; Argentina. Fil: Virkel, Guillermo. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Farías, Cristina. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Viviani, Paula. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Lanusse, Carlos. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Alvarez, L. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fil: Lifschitz, Adrián. Centro de Investigación Veterinaria de Tandil; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. 2021-03-03T15:53:54Z 2021-03-03T15:53:54Z 2021-01-26 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/8803 https://www.sciencedirect.com/science/article/abs/pii/S0304401721000224 0304-4017 https://doi.org/10.1016/j.vetpar.2021.109362 eng info:eu-repo/semantics/restrictedAccess application/pdf Elsevier Veterinary Parasitology 290 : 109362 (2021)
spellingShingle Ovinos
Infecciones por Nematodos
Medicamentos
Levamisol
Resistencia a los Antihelmínticos
Argentina
Sheep
Nematode Infections
Drugs
Levamisole
Resistence to Anthelmintics
Luque Sonia
Lloberas, María Mercedes
Cardozo, Patricia Alejandra
Virkel, Guillermo
Farias, Cristina
Viviani, Paula
Lanusse, Carlos Edmundo
Alvarez, L.
Lifschitz, Adrian Luis
Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs
title Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs
title_full Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs
title_fullStr Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs
title_full_unstemmed Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs
title_short Combined moxidectin-levamisole treatment against multidrug-resistant gastrointestinal nematodes: A four-year efficacy monitoring in lambs
title_sort combined moxidectin levamisole treatment against multidrug resistant gastrointestinal nematodes a four year efficacy monitoring in lambs
topic Ovinos
Infecciones por Nematodos
Medicamentos
Levamisol
Resistencia a los Antihelmínticos
Argentina
Sheep
Nematode Infections
Drugs
Levamisole
Resistence to Anthelmintics
url http://hdl.handle.net/20.500.12123/8803
https://www.sciencedirect.com/science/article/abs/pii/S0304401721000224
https://doi.org/10.1016/j.vetpar.2021.109362
work_keys_str_mv AT luquesonia combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT lloberasmariamercedes combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT cardozopatriciaalejandra combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT virkelguillermo combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT fariascristina combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT vivianipaula combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT lanussecarlosedmundo combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT alvarezl combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs
AT lifschitzadrianluis combinedmoxidectinlevamisoletreatmentagainstmultidrugresistantgastrointestinalnematodesafouryearefficacymonitoringinlambs